Bio-Techne Corp (TECH) Stock Price, Quote & News

Company Profile

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth f...

Industry: Biotechnology

Sector: Healthcare

Phone: 612 379 8854

Fax: 612 656 4400

Website: www.bio-techne.com

Address:

614 McKinley Place N.E., Minneapolis, United States

TradeSun Jul. 2 at 1:25 PM

$ALT Regarding the question about growing short interest: I’ve noticed several times that short interest increased significantly and kept rising right up until the buyout of certain biotech companies. I asked ChatGPT to list the major biotech buyouts in 2026. The results are $TECH, $APGE, and $FOLD. Interestingly, all of them showed elevated or growing short interest leading up to the acquisition announcement. 👇

0 · Reply

LewisDaKat Jun. 26 at 10:30 AM

$TECH TECH Price Target Alert: $73.00. Issued by Deutsche Bank https://marketwirenews.com/stock/tech/news/tech-price-target-alert-73-00-issued-by-deutsche-ban-5447941763202062.html?utm_source=stocktwits

0 · Reply

LewisDaKat Jun. 26 at 10:00 AM

$TECH Hold Recommendation Issued On TECH By Deutsche Bank https://marketwirenews.com/stock/tech/news/hold-recommendation-issued-on-tech-by-deutsche-bank-5939493996299149.html?utm_source=stocktwits

0 · Reply

TNNStockAnalysisNews Jun. 26 at 5:58 AM

$AYI +21.5% $TECH +20.09% $MU +15.78% $SNDK +17.4% $QCOM +9% to +10% https://truthsandnews.com/markets/top-stock-gainers-today-june-25-2026

0 · Reply

LewisDaKat Jun. 25 at 10:00 PM

$TECH Stock Market Today, June 25: Bio-Techne Surges After Merck KGaA Announces $73-PER-SHARE Cash Acquisition Offer https://marketwirenews.com/stock/tech/news/stock-market-today-june-25-bio-techne-surges-after-m-7238764970778849.html?utm_source=stocktwits

0 · Reply

LewisDaKat Jun. 25 at 6:30 PM

$TECH TECH Price Target Alert: $73.00. Issued by Leerink Partners https://marketwirenews.com/stock/tech/news/tech-price-target-alert-73-00-issued-by-leerink-part-7973092496092934.html?utm_source=stocktwits

0 · Reply

Olivia_Strickland Jun. 25 at 5:55 PM

$TECH gapping to 70.50, up almost 20% on the session, Merck buying them out for $11.3B. M&A names like this usually pin near the deal price and go dead. anyone playing the arb spread here or just letting it sit? this is what my scanner flagged: https://tapeboard.com/scanner?utm_source=stocktwits&utm_medium=post&utm_campaign=olivia&utm_content=tech-bk-up-scanner&utm_term=scanner&s=TECH

0 · Reply

lecorb Jun. 25 at 4:54 PM

$MU $SNDK $TECH $BB $KYMR 👏🏼👏🏼👏🏼👊🏻👊🏻👊🏻

0 · Reply

TFars Jun. 25 at 3:40 PM

$TECH had a small position that I was building in my multi bagger account. Sold this morning. Getting bought out is definitely a risk when researching companies of this nature. On to finding a replacement or just adding to existing names.

0 · Reply

wallfatz Jun. 25 at 3:36 PM

$TECH Good call dude

0 · Reply

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LCI Industries (NYSE – LCII), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH), Arcosa, Inc. (NYSE – ACA)

ACA IRDM

2026-06-30T11:10:17.000Z - 4 days ago

Bio-Techne downgraded to Hold from Buy at Benchmark

2026-06-29T21:40:09.000Z - 4 days ago

Bio-Techne downgraded to Hold from Buy at TD Cowen

2026-06-26T21:00:17.000Z - 7 days ago

Bio-Techne downgraded to Neutral from Buy at Citi

2026-06-26T12:30:47.000Z - 8 days ago

Bio-Techne downgraded to Equal Weight from Overweight at Stephens

2026-06-26T10:45:32.000Z - 8 days ago

Bio-Techne price target raised to $73 from $49 at Baird

2026-06-26T08:35:23.000Z - 8 days ago

Bio-Techne downgraded to Hold from Buy at Deutsche Bank

2026-06-25T22:05:09.000Z - 8 days ago

Bio-Techne downgraded to Market Perform from Outperform at William Blair

2026-06-25T16:05:08.000Z - 9 days ago

Bio-Techne rises 19.7%

2026-06-25T15:25:15.000Z - 9 days ago

Bio-Techne downgraded to Market Perform from Outperform at Leerink

2026-06-25T14:00:12.000Z - 9 days ago

Bio-Techne rises 19.2%

Jun 25, 2026, 8:00 AM EDT - 9 days ago

Bio-Techne Proxy statement: Proxy filing

Jun 25, 2026, 7:18 AM EDT - 9 days ago

Germany's Merck Is Buying Bio-Techne for $11.3 Billion

2026-06-25T10:20:20.000Z - 9 days ago

Merck KGaA to acquire Bio-Techne for $73 per share in cash

Jun 25, 2026, 6:10 AM EDT - 9 days ago

Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

Jun 25, 2026, 6:09 AM EDT - 9 days ago

Germany's Merck to buy Bio-Techne for $73 per share

Jun 25, 2026, 6:08 AM EDT - 9 days ago

Germany's Merck to Buy Bio-Techne for $11 Billion

2026-06-23T11:28:57.000Z - 11 days ago

Bio-Techne named a best smid-cap idea at TD Cowen

2026-06-11T09:57:41.000Z - 23 days ago

Bio-Techne initiated with a Neutral at Piper Sandler

Jun 4, 2026, 6:30 AM EDT - 4 weeks ago

Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization

2026-05-14T20:53:15.000Z - 7 weeks ago

Bio-Techne resumed with an Outperform at RBC Capital

May 12, 2026, 12:20 PM EDT - 7 weeks ago

Bio-Techne Transcript: Bank of America Global Healthcare Conference 2026

2026-05-08T16:09:43.000Z - 2 months ago

Bio-Techne price target lowered to $66 from $75 at Deutsche Bank

2026-05-07T15:37:56.000Z - 2 months ago

Bio-Techne price target lowered to $49 from $70 at Baird

May 6, 2026, 9:00 AM EDT - 2 months ago

Bio-Techne Earnings Call Transcript: Q3 2026

May 6, 2026, 9:00 AM EDT - 2 months ago

Bio-Techne Earnings release: Q3 2026

May 6, 2026, 9:00 AM EDT - 2 months ago

Bio-Techne Quarterly report: Q3 2026

May 6, 2026, 7:21 AM EDT - 2 months ago

Bio-Techne misses revenue estimates as US academic funding cuts dent demand

May 6, 2026, 6:30 AM EDT - 2 months ago

Bio-Techne Releases Third Quarter Fiscal 2026 Results

May 6, 2026, 6:30 AM EDT - 2 months ago

Bio-Techne Declares Dividend

May 4, 2026, 7:00 AM EDT - 2 months ago

Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference

Apr 16, 2026, 8:00 AM EDT - 2 months ago

Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

Apr 14, 2026, 7:00 AM EDT - 2 months ago

Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results

Mar 25, 2026, 6:30 AM EDT - 3 months ago

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite

Mar 10, 2026, 8:40 AM EDT - 4 months ago

Bio-Techne Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 11:10 AM EST - 4 months ago

Bio-Techne Transcript: TD Cowen 46th Annual Health Care Conference

Feb 24, 2026, 7:00 AM EST - 4 months ago

Bio-Techne to Present at Upcoming Investor Conferences

Feb 16, 2026, 6:30 AM EST - 4 months ago

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

Feb 11, 2026, 9:00 AM EST - 5 months ago

Bio-Techne Announces Changes to its Leadership Team

Feb 4, 2026, 9:00 AM EST - 5 months ago

Bio-Techne Earnings Call Transcript: Q2 2026

Feb 4, 2026, 9:00 AM EST - 5 months ago

Bio-Techne Quarterly report: Q2 2026

Feb 4, 2026, 9:00 AM EST - 5 months ago

Bio-Techne Earnings release: Q2 2026

Feb 4, 2026, 8:11 AM EST - 5 months ago

Biotech firm Bio-Techne beats quarterly estimates on strength in key unit

Feb 4, 2026, 6:30 AM EST - 5 months ago

Bio-Techne Releases Second Quarter Fiscal 2026 Results

Feb 2, 2026, 6:30 AM EST - 5 months ago

Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative

Jan 28, 2026, 6:30 AM EST - 5 months ago

Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers

Jan 20, 2026, 7:00 AM EST - 5 months ago

Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results

Jan 13, 2026, 12:00 PM EST - 6 months ago

Bio-Techne Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 8:00 PM EST - 6 months ago

Bio-Techne Slides: Corporate presentation

Dec 23, 2025, 7:00 AM EST - 6 months ago

Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference

Dec 9, 2025, 6:30 AM EST - 7 months ago

Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis

Dec 9, 2025, 4:30 AM EST - 7 months ago

Bio-Techne Transcript: 53rd Annual Nasdaq Investor Conference

Dec 3, 2025, 3:15 PM EST - 7 months ago

Bio-Techne Transcript: Citi Annual Global Healthcare Conference 2025

Dec 2, 2025, 8:20 AM EST - 7 months ago

Bio-Techne Transcript: Evercore ISI 8th Annual HealthCONx Conference

Nov 20, 2025, 7:30 AM EST - 8 months ago

Bio-Techne Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 9:00 AM EST - 8 months ago

Bio-Techne Transcript: Stephens Annual Investment Conference

Nov 18, 2025, 6:30 AM EST - 8 months ago

Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

Nov 11, 2025, 9:20 AM EST - 8 months ago

Bio-Techne Transcript: Stifel 2025 Healthcare Conference

Nov 10, 2025, 10:15 AM EST - 8 months ago

Bio-Techne Transcript: UBS Global Healthcare Conference 2025

Nov 5, 2025, 9:00 AM EST - 8 months ago

Bio-Techne Earnings Call Transcript: Q1 2026

Nov 5, 2025, 9:00 AM EST - 8 months ago

Bio-Techne Quarterly report: Q1 2026

Nov 5, 2025, 9:00 AM EST - 8 months ago

Bio-Techne Earnings release: Q1 2026

Nov 5, 2025, 7:22 AM EST - 8 months ago

Bio-Techne misses quarterly sales estimates on weak biotech demand

Nov 5, 2025, 6:30 AM EST - 8 months ago

Bio-Techne Releases First Quarter Fiscal 2026 Results

Nov 5, 2025, 6:30 AM EST - 8 months ago

BIO-TECHNE DECLARES DIVIDEND

Nov 4, 2025, 9:01 AM EST - 8 months ago

AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients

Nov 3, 2025, 7:00 AM EST - 8 months ago

ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics

Oct 30, 2025, 9:00 AM EDT - 8 months ago

Bio-Techne Transcript: AGM 2025

Oct 28, 2025, 6:30 AM EDT - 8 months ago

Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research

Oct 23, 2025, 7:00 AM EDT - 9 months ago

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital

Oct 15, 2025, 9:00 AM EDT - 9 months ago

Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents

Oct 15, 2025, 7:00 AM EDT - 9 months ago

Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results

Oct 9, 2025, 7:00 AM EDT - 9 months ago

Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032

Sep 26, 2025, 6:30 AM EDT - 10 months ago

Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications

Sep 24, 2025, 6:59 AM EDT - 10 months ago

Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report

Sep 19, 2025, 8:00 AM EDT - 10 months ago

Bio-Techne Proxy statement: Proxy Filing

Sep 19, 2025, 8:00 AM EDT - 10 months ago

Bio-Techne Proxy statement: Proxy Filing

Sep 10, 2025, 10:45 AM EDT - 10 months ago

Bio-Techne Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 9:05 AM EDT - 10 months ago

Bio-Techne Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 7:00 AM EDT - 10 months ago

ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California

Sep 3, 2025, 10:15 AM EDT - 10 months ago

Bio-Techne Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 14, 2025, 7:00 AM EDT - 11 months ago

ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory

Aug 6, 2025, 9:00 AM EDT - 11 months ago

Bio-Techne Earnings Call Transcript: Q4 2025

Aug 6, 2025, 9:00 AM EDT - 11 months ago

Bio-Techne Annual report: Q4 2025

Aug 6, 2025, 9:00 AM EDT - 11 months ago

Bio-Techne Earnings release: Q4 2025

Aug 6, 2025, 8:08 AM EDT - 11 months ago

Bio-Techne beats quarterly estimates on strength in protein sciences unit

Aug 6, 2025, 6:30 AM EDT - 11 months ago

Bio-Techne Releases Fourth Quarter Fiscal 2025 Results

Aug 5, 2025, 4:30 PM EDT - 11 months ago

Bio-Techne Announces Exosome Diagnostics Divestiture

Aug 5, 2025, 7:00 AM EDT - 11 months ago

ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine

Jul 31, 2025, 9:52 AM EDT - 1 year ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH DXCM EW ISRG LLY PODD

Jul 31, 2025, 7:00 AM EDT - 1 year ago

ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering

Jul 17, 2025, 7:00 AM EDT - 1 year ago

Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results

Jul 15, 2025, 9:03 AM EDT - 1 year ago

Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology

Jul 15, 2025, 7:00 AM EDT - 1 year ago

Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection

TradeSun Jul. 2 at 1:25 PM

0 · Reply

LewisDaKat Jun. 26 at 10:30 AM

0 · Reply

LewisDaKat Jun. 26 at 10:00 AM

$TECH Hold Recommendation Issued On TECH By Deutsche Bank https://marketwirenews.com/stock/tech/news/hold-recommendation-issued-on-tech-by-deutsche-bank-5939493996299149.html?utm_source=stocktwits

0 · Reply

TNNStockAnalysisNews Jun. 26 at 5:58 AM

$AYI +21.5% $TECH +20.09% $MU +15.78% $SNDK +17.4% $QCOM +9% to +10% https://truthsandnews.com/markets/top-stock-gainers-today-june-25-2026

0 · Reply

LewisDaKat Jun. 25 at 10:00 PM

0 · Reply

LewisDaKat Jun. 25 at 6:30 PM

0 · Reply

Olivia_Strickland Jun. 25 at 5:55 PM

0 · Reply

lecorb Jun. 25 at 4:54 PM

$MU $SNDK $TECH $BB $KYMR 👏🏼👏🏼👏🏼👊🏻👊🏻👊🏻

0 · Reply

TFars Jun. 25 at 3:40 PM

0 · Reply

wallfatz Jun. 25 at 3:36 PM

$TECH Good call dude

0 · Reply

Olivia_Strickland Jun. 25 at 1:55 PM

$TECH popping 19% to 70 on the Merck KGaA buyout, 11.3B all cash. these deal pops usually pin near the offer and grind sideways from here, no real trade left unless arb is your thing. anyone playing the spread or just moving on? this is what my scanner flagged: https://tapeboard.com/scanner?utm_source=stocktwits&utm_medium=post&utm_campaign=olivia&utm_content=tech-bk-up-scanner&utm_term=scanner&s=TECH

0 · Reply

shitzushimazu Jun. 25 at 1:55 PM

$TECH I guess exactly there. I sold most of my shares for 58 assuming it would eventually sell off again. Oh well gains a gain. I would be more disappointed after holding this into S&P inclusion to get a 80 point haircut to then only get offered half of the orginal inclusion market cap.

0 · Reply

topstockalerts Jun. 25 at 12:48 PM

Pre Market Top Gainers PT2 $FCUV $NEXR $TECH $EHGO $MU

0 · Reply

briefingcom Jun. 25 at 12:39 PM

$TECH: Bio-Techne (+19.4%) to be acquired by Merck KG&A (MKKGY) for $73/share in cash.

0 · Reply

topstockalerts Jun. 25 at 12:04 PM

Pre Market Top Gainers PT2 $FCUV $TECH $ZTEK $MU $MEI

0 · Reply

OpenOutcrier Jun. 25 at 11:48 AM

$TECH (+19.9% pre) Merck KGaA to acquire Bio-Techne for $11.3 billion ($73/sh cash) https://ooc.bz/l/106169

0 · Reply

notreload_ai Jun. 25 at 10:33 AM

Germany’s Merck KGaA has agreed to buy U.S.-based $TECH for $11.3 billion in cash, strengthening its life sciences portfolio with advanced research tools and platforms. https://notreload.xyz/xy/merck-bolsters-life-sciences-portfolio-with-bio-techne-acquisition/

0 · Reply

khalidsameer001 Jun. 25 at 10:01 AM

$TECH ok... some kind of deal. makes sense.

0 · Reply

khalidsameer001 Jun. 25 at 10:00 AM

$TECH super illiquid..... big cap.... just chilling in the air at 6 AM.... lol

0 · Reply

khalidsameer001 Jun. 25 at 9:44 AM

$TECH up on no apparent news? on 15,000 shares.... lol

0 · Reply

SuperGreenToday Jun. 23 at 5:13 AM

$TECH Share Price: $55.61 Contract Selected: Oct 16, 2026 $55 Calls Buy Zone: $2.14 – $2.65 Target Zone: $3.67 – $4.49 Potential Upside: 62% ROI Time to Expiration: 115 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

SuperGreenToday Jun. 16 at 11:28 PM

$TECH Share Price: $56.03 Contract Selected: Oct 16, 2026 $55 Calls Buy Zone: $4.50 – $5.57 Target Zone: $8.16 – $9.97 Potential Upside: 71% ROI Time to Expiration: 121 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Market Cap	11.09B
Revenue (ttm)	1.22B
Net Income (ttm)	73.40M
EPS (ttm)	N/A
PE Ratio	40.80
Forward PE	40.34
Profit Margin	6.02%
Debt to Equity Ratio	0.10

Volume	7,826,200
Avg Vol	4,979,326
Day's Range	N/A - N/A
Shares Out	156.57M
Stochastic %K	97%
Beta	1.29
Analysts	Sell
Price Target	$67.15